CNTX Context Therapeutics Inc

  0%
Previous Close
Open
52 Week Low
52 Week High
Market Cap $0
Shares 6,876,716
Float 5,971,554
Enterprise Value $0
Volume 0
Av. Daily Volume 0
Stock charts supplied by TradingView

Upcoming Catalysts

Drug Stage Catalyst Date
Onapristone (ONA-XR)
Ovarian cancer
Phase 2
Phase 2
Premium membership is required to view catalyst dates, analyst ratings, earnings dates and cash burn data. Click here to unlock and sign up to a 14-day FREE TRIAL.
Onapristone (ONA-XR) - (ONAWA)
Breast Cancer
Phase 1
Phase 1
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.
Onapristone (ONA-XR) and Anastrozole
Endometrial Cancer
Phase 2
Phase 2
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque sapien.

Drug Pipeline

Drug Stage Notes
FEMARA (Letrozole) IBRANCE (Palbociclib) and Onapristone (ONA-XR)
Breast cancer - first line
Phase 2
Phase 2
Phase 2 trial to be initiated mid-2021.
Onapristone (ONA-XR) and Fulvestrant (The SMILE Study)
Breast Cancer - 2nd-line
Phase 2
Phase 2
Phase 2 trial is ongoing.